Can Benitec Biopharma Limited Ads (NASDAQ:BNTC)’s Tomorrow be Different? The Stock Had Increase in Shorts

May 19, 2017 - By Henry Gaston

 Can Benitec Biopharma Limited Ads (NASDAQ:BNTC)’s Tomorrow be Different? The Stock Had Increase in Shorts

The stock of Benitec Biopharma Limited Ads (NASDAQ:BNTC) registered an increase of 6.52% in short interest. BNTC’s total short interest was 106,200 shares in May as published by FINRA. Its up 6.52% from 99,700 shares, reported previously. With 62,400 shares average volume, it will take short sellers 2 days to cover their BNTC’s short positions. The short interest to Benitec Biopharma Limited Ads’s float is 1.89%. About 60,309 shares traded. Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Benitec Biopharma Limited is a biotechnology company. The company has market cap of $23.18 million. The Firm is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property ; development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. It currently has negative earnings. The Company’s In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic.

More important recent Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) news were published by: Quotes.Wsj.com which released: “Benitec Biopharma Ltd. ADR BNTC (US: Nasdaq)” on July 31, 2015, also Marketwatch.com published article titled: “2.26”, Wallstreetpr.com published: “Why Benitec Biopharma Ltd (ADR)(NASDAQ:BNTC) Is In Focus?” on February 08, 2017. More interesting news about Benitec Biopharma Ltd (ADR) (NASDAQ:BNTC) was released by: Schaeffersresearch.com and their article: “Edwards Lifesciences, Benitec Biopharma, Stemline Therapeutics Stocks Moving Today” with publication date: February 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.